The journal of China Oncology (ISSN 1007-3639, CN 31-1727/R) started in 1991, is a peer-reviewed monthly publication, integrating scientific information from global sources for all oncologic specialties. It is an open access monthly published journal in Chinese and English. The competent authorities of China Oncology is the Ministry of Education of the People’s Republic of China. China Oncology is hosted by one of the most prestigious comprehensive cancer centers, the Fudan University Shanghai Cancer Center. China Oncology mainly reports on cutting-edge research in the field of scientific information from global sources across all oncologic specialties, focusing on the latest research results in clinical, basic, and translational oncology, and featuring research articles, editorial comments, reviews, guidelines, and case reports. China Oncology promotes the exchange of research achievements in the field of oncology in China, improves the level of cancer prevention and treatment, promotes the Healthy China strategy, and provides a platform for academic exchange and presentation for authors and readers.

At present, China Oncology is indexed in the following most powerful database: SCOPUS, DOAJ, Chemical Abstracts (CAS), EMBASE, EBSCO, Japan Science and Technology Database (JST), Index of Copernicus International (ICI), EuroPub and Western Pacific Region Index Medicus (WPRIM),  Ulrich's Periodical Directory, Chinese Science Citation Database (CSCD), A Guide to the Core Journal of China, Chinese Scientific and Technical Papers and Citations Database (CSTPCD), Chinese Academic Journal Comprehensive Evaluation Database (CAJCED), Chinese Medical Current Content (CMCC), Chinese Medical Citation Index (CMCI),Chinese Biological Abstracts (CBA), EuroPub, GoOA, COAJ, Level A of Fudan University degree and Graduate Education Domestic Journals Guideline, Research Center for Chinese Science Evaluation (RCCSE), World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (up to 2024). Besides, China Oncology continuously acquired Certificate of Outstanding S&T Journals of China (F5000) since 2017. 

As a leading comprehensive oncology journal in China, the objective of China Oncology is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines.

China Oncology achieves this objective by publishing original research contents on basic medicine, clinical medicine, epidemiology, etc., with the columns of research articles, editorial comments, review, guidelines and case report.  In addition, China Oncology also publishes special themed issues that present solicited review articles of current interest authored by globally recognized clinical oncologists and scientists. The special themed issues are published at least 2 times annually. 

China Oncology publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines:
   Blood/bone marrow
   Breast disease
   Epidemiology
   Pathology
   Diagnosis of cancer
   Gastrointestinal tract
   Genitourinary disease
   Gynecologic oncology
   Head and neck cancer
   Hepatobiliary malignancies
   Lung cancer
   Medical oncology
   Radiation oncology
   Surgical oncology
   Neuro-oncology
   Translational research 

Readership
Surgical, medical, and radiation oncologists; gynecologists; urologists; pathologists, diagnostic radiologists; basic scientists in oncology; epidemiologists.

Open Access License Statement

China Oncology is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-Non-Commercial-NoDerivs 4.0 (CC-BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.

Free access and usage 

Permitted the third party to reuse is defined by the CC-BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:
· This is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
· The user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
· No derivatives including remix, transform, or build upon the material was allowed for distribution.
The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/

Editor-in-Chief

Prof. SHAO Zhimin 

Honorary Editor-in-Chief
Prof. TANG Zhaoyou, Prof. CAO Shilong, Prof. SHEN Zhenzhou

Competent Authorities
The Ministry of Education of the People’s Republic of China

Sponsored by
Fudan University Shanghai Cancer Center

Edited by
Editorial Board of China Oncology

Director of the Editorial Department
NI Ming

Editorial Office
Journal of China Oncology
Fudan University Shanghai Cancer Center 270 Dong’an Road Shanghai, 200032

The People’s Republic of China